Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
3 355,90 ₹
+1,72%
(+56,90) 1D
15 қаз., 13:31:16 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
3 330,00 ₹
High
3 387,70 ₹
Low
3 313,70 ₹
Mkt. cap
419,35 млрд
Avg. vol.
92,18 мың
Volume
61,19 мың
Dividend
1,58%
Quarterly dividend
13,25 ₹
Ex-dividend date
2026 ж. 05 там.
P/E ratio
36,95
52-wk high
3 796,00 ₹
52-wk low
2 382,00 ₹
EPS
90,83 ₹
Shares outstanding
88,45 млн
No. of employees
10 мың
Open
3 330,00 ₹
High
3 387,70 ₹
Low
3 313,70 ₹
Mkt. cap
419,35 млрд
Avg. vol.
92,18 мың
Volume
61,19 мың
Dividend
1,58%
Quarterly dividend
13,25 ₹
Ex-dividend date
2026 ж. 05 там.
P/E ratio
36,95
52-wk high
3 796,00 ₹
52-wk low
2 382,00 ₹
EPS
90,83 ₹
Shares outstanding
88,45 млн
No. of employees
10 мың
News stories
From web sources and news partners
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10,4 мың
Founded1973
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 30 шіл.
Fiscal period
Q1 2027
26,72 ₹ / 22,90 ₹
+16,68%beat
Revenue / Est. (INR)
16,26 млрд / 15,30 млрд
+6,26%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
13,54 млрд
13,75 млрд
14,22 млрд
16,26 млрд
Cost of goods sold
3,17 млрд
2,86 млрд
3,85 млрд
3,28 млрд
Cost of revenue
3,17 млрд
2,86 млрд
3,85 млрд
3,28 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,17 млрд
3,31 млрд
3,50 млрд
3,81 млрд
Operating expense
7,11 млрд
7,50 млрд
7,05 млрд
8,88 млрд
Total operating expenses
10,28 млрд
10,36 млрд
10,90 млрд
12,16 млрд
Operating income
3,26 млрд
3,39 млрд
3,32 млрд
4,10 млрд
Other non operating income
197,10 млн
164,20 млн
-447,90 млн
204,30 млн
EBT including unusual items
3,41 млрд
3,59 млрд
3,47 млрд
4,47 млрд
EBT excluding unusual items
3,41 млрд
3,59 млрд
4,42 млрд
4,47 млрд
Income tax expense
806,20 млн
848,30 млн
804,10 млн
1,13 млрд
Effective tax rate
23,66%
23,66%
23,17%
25,20%
Other operating expenses
3,51 млрд
3,76 млрд
3,09 млрд
4,63 млрд
Net income
2,60 млрд
2,74 млрд
2,67 млрд
3,34 млрд
Net profit margin
19,22%
19,91%
18,76%
20,56%
Earnings per share
20,82
21,91
21,34
26,72
Interest and investment income
-
-
516,00 млн
-
Interest expense
-33,90 млн
-51,00 млн
-23,60 млн
-31,80 млн
Net interest expenses
-33,90 млн
-51,00 млн
492,40 млн
-31,80 млн
Depreciation and amortization charges
429,70 млн
435,10 млн
453,70 млн
445,00 млн
EBITDA
3,68 млрд
3,70 млрд
3,70 млрд
4,49 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары